011HO12155 ALTAALTUVE*RC

Print/PDF
Registration Name PEAK ALTAALTUVE-ET
Registration Number HO840003138499077
Primary NAAB Code 011HO12155
Secondary Code(s) 511HO12155
Status Inactive
Controller Name Alta Genetics (11)
Date of Birth 3/9/2017
aAa 234
DMS 123,126
GFI 12.8%
Genetic Codes * TD TL TC TV TY TP RC TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HHR-C
Sire MR SALVATORE RC-ET
MGS VIEW-HOME MONTEREY-ET
Beta Casein A1A1
Kappa Casein BB
Beta Lactoglobulin AA
INDEXES
NM$ 318, 91% R CM$ 326
NM Percentile 33% FM$ 302
GTPI 2833 GM$ 258
PRODUCTION TRAITS
8248 Dtrs 1383 herds 8 % US 99% R
Milk 1317 Fat, % 36 , -0.07%
SCS 2.86, 98% R Protein, % 43 , 0.00%
Feed Saved -53 , 59% R Milking Speed 6.37 , 81% R
Health & Fertility
Productive Life 0.5      96% R Mastitis 0.7      90% R
Heifer Livability 1.1       76% R Metritis 1.1      83% R
Livability -2.5      87% R D. Abom 0.0      87% R
DPR -2.4      97% R Ketosis 0.0      82% R
FSC -9.7      97% R R. Placenta 0.4      85% R
HCR -1.5      94% R Milk Fever 0.0      74% R
CCR -3.6      97% R
SCR -        -
DIA -0.4      51% R
RSP -1.5      67% R
Calving Traits
Sire CE 1.4      97% R 8413 Obs
Daughter CE 2.1      92% R 395 Obs, 3558 Dtrs
Sire SB 3.9      92% R 13109 Obs
Daughter SB 3.7      91% R 299 Obs, Dtrs
Gestation Length -0.6      99% R 139 Obs, 1660 Dtrs
Early First Calving 2.1      93% R 63 Obs, 454 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
3275 Dtrs 663 herds 96% R
PTA Type 1.19 UDC -0.28
HCC -0.24 BWC 0.05
FLC 0.82
Linear Traits
Stature 1.87
Tall
Strength 0.59
Strong
Body Depth 1.24
Deep
Dairy Form 2.55
Open
Rump Angle -0.46
Flat
Thurl Width 1.76
Flat
Rear Legs-Side View 1.76
Wide
Rear Legs-Rear View 1.61
Straight
Foot Angle 0.04
Steep
Feet & Legs Score 1.26
High
F.U. Attachment 2.69
Curved
Rear Udder Height 0.90
High
Rear Udder Width 1.27
Wide
Udder Cleft -0.82
Weak
Udder Depth 1.61
Straight
Front Teat Placement 0.04
Close
Rear Teat Placement -0.95
Wide
Teat Length 0.93
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO